<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8418">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02152904</url>
  </required_header>
  <id_info>
    <org_study_id>KPUB</org_study_id>
    <nct_id>NCT02152904</nct_id>
  </id_info>
  <brief_title>Risk Factors of Rebleeding After Peptic Ulcer Bleeding: a Nationwide Cohort Study</brief_title>
  <acronym>KPUB</acronym>
  <official_title>Risk Factors of Rebleeding After Peptic Ulcer Bleeding: a Nationwide Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Joon Sung Kim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Incheon St.Mary's Hospital</source>
  <oversight_info>
    <authority>Korea: National Strategic Coordinating Center for Clinical Research</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the investigators study is to investigate the factors associated with
      rebleeding in patients with peptic ulcer bleeding.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators are performing a nationwide population based cohort study to investigate
      the factors associated with rebleeding in patients with peptic ulcer bleeding. The results
      of the investigators study should give us information about patients who are at high risk of
      rebleeindg and enable us to manage these patients appropriately.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Rebleeding rate of peptic ulcer bleeding</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>The rebleeding rate of patients diagnosed with peptic ulcer ble4eding</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality rates of peptic ulcer bleeding</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>The 30 day mortality rate of patients diagnosed with peptic ulcer bleeding</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Peptic Ulcer Bleeding</condition>
  <arm_group>
    <arm_group_label>Peptic ulcer bleeding patients</arm_group_label>
    <description>Endoscopy</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who visit the hospital with symptoms suggestive of peptic ulcer bleeding such as
        melena or hematemesis. These patients recieve endoscopy and when they are diagnosed with
        peptic ulcer bleeding are eligible for enrollment.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients diagnosed with peptic ulcer bleeding by endoscopy

          -  Patients who consent to be enrolled in the study

        Exclusion Criteria:

          -  Patients who refuse to be enrolled in the study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Byung-Wook Kim, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Incheon St. Mary's Hospital, The Catholic University of Korea</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Byung Wook Kim, Ph.D.</last_name>
    <email>gastro@catholic.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joon Sung Kim</last_name>
    <email>kijoons@catholic.ac.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Incheon St. Mary's Hospital</name>
      <address>
        <city>Incheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Byung-Wook Kim, Ph.D.</last_name>
      <email>gastro@catholic.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Joon Sung Kim</last_name>
      <email>kijoons@catholic.ac.kr</email>
    </contact_backup>
    <investigator>
      <last_name>Byung-Wook Kim, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 30, 2014</lastchanged_date>
  <firstreceived_date>May 29, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Incheon St. Mary's hospital</investigator_affiliation>
    <investigator_full_name>Joon Sung Kim</investigator_full_name>
    <investigator_title>Clinical assistant proffessor, Department of Internal medicine, Incheon St. Mary's Hospital</investigator_title>
  </responsible_party>
  <keyword>Peptic ulcer bleeding</keyword>
  <keyword>rebleeding</keyword>
  <keyword>mortality</keyword>
  <keyword>nationwide</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Peptic Ulcer</mesh_term>
    <mesh_term>Peptic Ulcer Hemorrhage</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
